2026-09-21 19:55:53
Eli Lilly Breaks Ground on $6.5B Houston Plant as CEO Says Foundayo Captures One-Third of New GLP-1 Oral Starts
According to CEO Dave Ricks, Eli Lilly on Monday broke ground on a $6.5 billion manufacturing plant in Houston, expected to begin production in 2030. The facility will produce Foundayo, Lilly's newly launched oral obesity drug, alongside active ingredients for cardiometabolic, cancer, immunology, an